C. Miyaki

发表

Production of H5N1 (NIBRG-14) inactivated whole virus and split virion influenza vaccines and analysis of immunogenicity in mice using different adjuvant formulations.

E. Miyaji, I. Raw, H. G. Higashi, 2010, Vaccine.

Vitamins as influenza vaccine adjuvant components

F. A. de Freitas, I. Raw, D. Rodriguez, 2016, Archives of Virology.

Vero-cell rabies vaccine produced using serum-free medium.

I. Raw, H. G. Higashi, C. Miyaki, 2004, Vaccine.

H7N9 pandemic preparedness: A large-scale production of a split inactivated vaccine.

R. Oliveira, C. Y. Takano, I. Raw, 2021, Biochemical and biophysical research communications.

Influenza vaccine production for Brazil: a classic example of successful North-South bilateral technology transfer.

A. Precioso, I. Raw, C. Miyaki, 2011, Vaccine.

Bordetella pertussis monophosphoryl lipid A as adjuvant for inactivated split virion influenza vaccine in mice.

E. Miyaji, L. Leite, C. S. Takata, 2009, Vaccine.

[Susceptibility of Vero cell line to vaccine strains of the measles virus].

C. S. Takata, C. Miyaki, F. Kubrusly, 1994, Revista de saude publica.

Enhancement of plaque formation of herpes simplex virus (HSV) and varicella-zoster virus (VZV) by subinhibitory dose of acyclovir (ACV).

K. Yamanishi, K. Shiraki, C. Miyaki, 1989, Acta virologica.

Sorbitol-gelatin and glutamic acid-lactose solutions for stabilization of reference preparations of measles virus.

C. S. Takata, N. M. Gallina, C. Miyaki, 1989, Bulletin of the Pan American Health Organization.

Identification of mycoplasma samples isolated from cell cultures by the growth inhibition test

J. Timenetsky, C. Miyaki, E. Rizzo, 1992 .

Vitamins as influenza vaccine adjuvant components

F. A. de Freitas, I. Raw, D. Rodriguez, 2016, Archives of Virology.